Sage Therapeutics’ stock falls 4.7% as biotech unveils plan to cut 33% of workforce
More than 165 jobs to go as company seeks to extend cash runway and focus on postpartum drug launch.
More than 165 jobs to go as company seeks to extend cash runway and focus on postpartum drug launch.
